Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: A meta-analysis

Maurice P A Zeegers, Annemarie Jellema, Harry Ostrer

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

BACKGROUND. Although narrative reviews have concluded that there is strong support for familial clustering of prostate carcinoma, the association has never systematically been quantified in reviews. The purpose of this meta-analysis was to summarize and quantify the recurrence risk ratio with emphasis on the degree of relation, the specific relationship of the family member, the number of affected family members, and the age at diagnosis. METHODS. Publications were identified through computerized database searches for epidemiologic studies published up to December 2002. In addition, references cited in original and review papers were examined. Three blinded reviewers extracted both qualitative and quantitative information from each paper. Using random effects meta-regression analyses, the authors calculated summary recurrence risk ratios (Sλ). The reviewers also evaluated changes in Sλ according to differences in study methodology. RESULTS. Thirty-three epidemiologic studies were included in the current review. Sλ was 2.53 (95% confidence interval, 2.24-2.85) for first-degree family members. Sλ appeared to be greater for men with an affected brother than for men with an affected father. Sλ for men who had second-degree relatives with prostate carcinoma was only slightly elevated. The nature of the familial clustering is such that Sλ increases with decreasing age of the patient and family members, with increasing genetic relatedness of the affected relative, and with increasing number of individuals affected within a family. CONCLUSIONS. The studies that were reviewed consistently demonstrate that family history is a significant risk factor for development of prostate carcinoma.

Original languageEnglish (US)
Pages (from-to)1894-1903
Number of pages10
JournalCancer
Volume97
Issue number8
DOIs
StatePublished - Apr 15 2003
Externally publishedYes

Fingerprint

Meta-Analysis
Prostate
Carcinoma
Cluster Analysis
Epidemiologic Studies
Odds Ratio
Recurrence
Fathers
Publications
Siblings
Regression Analysis
Databases
Confidence Intervals

Keywords

  • Epidemiology
  • Family history
  • Meta-analysis
  • Prostate neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma : A meta-analysis. / Zeegers, Maurice P A; Jellema, Annemarie; Ostrer, Harry.

In: Cancer, Vol. 97, No. 8, 15.04.2003, p. 1894-1903.

Research output: Contribution to journalArticle

Zeegers, Maurice P A ; Jellema, Annemarie ; Ostrer, Harry. / Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma : A meta-analysis. In: Cancer. 2003 ; Vol. 97, No. 8. pp. 1894-1903.
@article{2b8144d27fe44d54ab4fe7462aaad1cd,
title = "Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: A meta-analysis",
abstract = "BACKGROUND. Although narrative reviews have concluded that there is strong support for familial clustering of prostate carcinoma, the association has never systematically been quantified in reviews. The purpose of this meta-analysis was to summarize and quantify the recurrence risk ratio with emphasis on the degree of relation, the specific relationship of the family member, the number of affected family members, and the age at diagnosis. METHODS. Publications were identified through computerized database searches for epidemiologic studies published up to December 2002. In addition, references cited in original and review papers were examined. Three blinded reviewers extracted both qualitative and quantitative information from each paper. Using random effects meta-regression analyses, the authors calculated summary recurrence risk ratios (Sλ). The reviewers also evaluated changes in Sλ according to differences in study methodology. RESULTS. Thirty-three epidemiologic studies were included in the current review. Sλ was 2.53 (95{\%} confidence interval, 2.24-2.85) for first-degree family members. Sλ appeared to be greater for men with an affected brother than for men with an affected father. Sλ for men who had second-degree relatives with prostate carcinoma was only slightly elevated. The nature of the familial clustering is such that Sλ increases with decreasing age of the patient and family members, with increasing genetic relatedness of the affected relative, and with increasing number of individuals affected within a family. CONCLUSIONS. The studies that were reviewed consistently demonstrate that family history is a significant risk factor for development of prostate carcinoma.",
keywords = "Epidemiology, Family history, Meta-analysis, Prostate neoplasms",
author = "Zeegers, {Maurice P A} and Annemarie Jellema and Harry Ostrer",
year = "2003",
month = "4",
day = "15",
doi = "10.1002/cncr.11262",
language = "English (US)",
volume = "97",
pages = "1894--1903",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma

T2 - A meta-analysis

AU - Zeegers, Maurice P A

AU - Jellema, Annemarie

AU - Ostrer, Harry

PY - 2003/4/15

Y1 - 2003/4/15

N2 - BACKGROUND. Although narrative reviews have concluded that there is strong support for familial clustering of prostate carcinoma, the association has never systematically been quantified in reviews. The purpose of this meta-analysis was to summarize and quantify the recurrence risk ratio with emphasis on the degree of relation, the specific relationship of the family member, the number of affected family members, and the age at diagnosis. METHODS. Publications were identified through computerized database searches for epidemiologic studies published up to December 2002. In addition, references cited in original and review papers were examined. Three blinded reviewers extracted both qualitative and quantitative information from each paper. Using random effects meta-regression analyses, the authors calculated summary recurrence risk ratios (Sλ). The reviewers also evaluated changes in Sλ according to differences in study methodology. RESULTS. Thirty-three epidemiologic studies were included in the current review. Sλ was 2.53 (95% confidence interval, 2.24-2.85) for first-degree family members. Sλ appeared to be greater for men with an affected brother than for men with an affected father. Sλ for men who had second-degree relatives with prostate carcinoma was only slightly elevated. The nature of the familial clustering is such that Sλ increases with decreasing age of the patient and family members, with increasing genetic relatedness of the affected relative, and with increasing number of individuals affected within a family. CONCLUSIONS. The studies that were reviewed consistently demonstrate that family history is a significant risk factor for development of prostate carcinoma.

AB - BACKGROUND. Although narrative reviews have concluded that there is strong support for familial clustering of prostate carcinoma, the association has never systematically been quantified in reviews. The purpose of this meta-analysis was to summarize and quantify the recurrence risk ratio with emphasis on the degree of relation, the specific relationship of the family member, the number of affected family members, and the age at diagnosis. METHODS. Publications were identified through computerized database searches for epidemiologic studies published up to December 2002. In addition, references cited in original and review papers were examined. Three blinded reviewers extracted both qualitative and quantitative information from each paper. Using random effects meta-regression analyses, the authors calculated summary recurrence risk ratios (Sλ). The reviewers also evaluated changes in Sλ according to differences in study methodology. RESULTS. Thirty-three epidemiologic studies were included in the current review. Sλ was 2.53 (95% confidence interval, 2.24-2.85) for first-degree family members. Sλ appeared to be greater for men with an affected brother than for men with an affected father. Sλ for men who had second-degree relatives with prostate carcinoma was only slightly elevated. The nature of the familial clustering is such that Sλ increases with decreasing age of the patient and family members, with increasing genetic relatedness of the affected relative, and with increasing number of individuals affected within a family. CONCLUSIONS. The studies that were reviewed consistently demonstrate that family history is a significant risk factor for development of prostate carcinoma.

KW - Epidemiology

KW - Family history

KW - Meta-analysis

KW - Prostate neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0037445964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037445964&partnerID=8YFLogxK

U2 - 10.1002/cncr.11262

DO - 10.1002/cncr.11262

M3 - Article

C2 - 12673715

AN - SCOPUS:0037445964

VL - 97

SP - 1894

EP - 1903

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 8

ER -